Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高級檢索
  • Fluciclovine is a potential im...
  • 引用
  • 發送短信
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • Permanent link
Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

書目詳細資料
Main Authors: Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL
格式: Conference item
語言:English
出版: Springer 2017
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

相似書籍

  • Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
    由: Teoh, E, et al.
    出版: (2017)
  • Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
    由: Scott, NP, et al.
    出版: (2021)
  • Cancer imaging with fluciclovine (18F)
    由: Teoh, E
    出版: (2018)
  • Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
    由: Morotti, M, et al.
    出版: (2020)
  • Glutamine deprivation alters the origin and function of cancer cell exosomes
    由: Fan, S, et al.
    出版: (2020)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題